9.88
+1.8(+22.28%)
Currency In USD
| Previous Close | 8.08 |
| Open | 7.95 |
| Day High | 9.9 |
| Day Low | 7.32 |
| 52-Week High | 24.5 |
| 52-Week Low | 3.44 |
| Volume | 2.48M |
| Average Volume | 1.38M |
| Market Cap | 72.92M |
| PE | -1.89 |
| EPS | -5.23 |
| Moving Average 50 Days | 7.32 |
| Moving Average 200 Days | 7.74 |
| Change | 1.8 |
If you invested $1000 in Biodesix, Inc. (BDSX) since IPO date, it would be worth $38.56 as of January 14, 2026 at a share price of $9.88. Whereas If you bought $1000 worth of Biodesix, Inc. (BDSX) shares 5 years ago, it would be worth $19.01 as of January 14, 2026 at a share price of $9.88.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
GlobeNewswire Inc.
Jan 12, 2026 11:00 AM GMT
Estimated Q4 2025 Revenue of $28.8 million, an increase of 41%; Grew full-year revenue to an estimated $88.5 million, an increase of 24%; Affirms guidance of Adjusted EBITDA positivity in Q4 2025. LOUISVILLE, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) -
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
GlobeNewswire Inc.
Dec 03, 2025 1:22 PM GMT
Clinical utility data for Nodify Lung® tests to be presented at North American Conference on Lung Cancer (NACLC) highlighting potential for earlier diagnosis of lung cancer Development data for a new ultra-sensitive ESR1 assay for breast cancer treat
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
GlobeNewswire Inc.
Oct 30, 2025 10:17 AM GMT
Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc.